Chiral recognition at self-assembled multivalent (SAMul) nanoscale interfaces &#8211; enantioselectivity in polyanion binding by Chan, Ching W. et al.
Chemical Communications c6cc04470k
Chiral Q1recognition at self-assembled multivalent
Q2(SAMul) nanoscale interfaces – enantioselectivity
in polyanion binding
Ching W. Chan, Erik Laurini, Paola Posocco,
Sabrina Pricl and David K. Smith*
We investigate structure–activity effect relationships at the
nanoscale chiral molecular recognition interface between
enantiomeric self-assembled multivalent (SAMul) systems
and biological polyanions, heparin and DNA.
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Chiral Q1 Q2recognition at self-assembled multivalent
(SAMul) nanoscale interfaces – enantioselectivity
in polyanion binding†
Ching W. Chan,a Erik Laurini,b Paola Posocco,b Sabrina Priclb and David K. Smith*a
Self-assembled multivalent (SAMul) ligands based on palmitic acid
functionalised with cationic L/D-lysine bind polyanionic heparin or
DNA with no chiral preference. Inserting a glycine spacer unit
switches on chiral discrimination – a rare example of controlled
chiral recognition at a SAMul nanoscale interface.
Molecular recognition at self-assembled surfaces is a key strategy
used by biological systems to organise ligands over nanometre
length scales, enabling adhesion to biomolecular targets.1 There
is increasing interest in synthetic supramolecular systems which
bind nanoscale biological targets,2 with multivalent binding
being of particular use.3 Self-assembly is a powerful strategy to
organise such interactions.4 We have been developing self-
assembled multivalent (SAMul) systems to bind polyanions such
as DNA5 and heparin,6 which have potential clinical relevance in
gene therapy,7 and blood coagulation control,8 respectively.
More broadly, it is worth noting that there are many polyanions
in biological systems – including cell membranes, micro-
filaments and tubules. Biology can control these polyanions
with precise selectivity – understanding and intervening in this
remains a real challenge.9 Self-assembled polycations are widely
used to bind polyanions.10 Selectivity at such binding interfaces
is primarily considered to be based on charge density;11 other
factors are known to modulate selectivity, but the number of
experimental examples is limited.12 We have therefore been
interested in exploring the subtleties of polyanion recognition.
We recently studied ligand modification in SAMul systems and
found different polyanions exhibited different ligand preferences.13
We have also studied chiral systems, and found ligand chirality
could enable enantioselective binding.14 Chiral micelles are known
to separate enantiomers in capillary electrophoresis, with the
low-molecular-weight analyte partitioning into the micelle,
close to the surfactant chiral centre,15 but this is somewhat
different to our report of chiral multivalent binding across the
self-assembled surface.14 However, the molecular structures in
our previous report were relatively complex, and we therefore
wanted to simplify our molecular design to probe the impact of
simple structural modifications on chiral ligand display.
In our new minimal design, Boc-protected L- or D-lysine was
coupled with 1-hexadecylamine using TBTU and Et3N in DCM,
with the desired compounds C16-L-Lys and C16-D-Lys being
obtained after removal of the protecting groups using HCl
gas in methanol. Similarly, the glycine-spaced compounds were
synthesised using solution-phase TBTU-mediated peptide cou-
pling and a Boc-protecting group strategy (see ESI†). The
syntheses worked in good yields, with circular dichroism (CD)
spectroscopy being used to confirm enantiomeric relation-
ships; each pair of compounds exhibited mirror-image spectra
(Table 1 and ESI†). The CD spectra of the compounds with and
without a glycine spacer were diﬀerent, reflecting the presence
of the additional UV-chromophoric peptide bond Q3(Fig. 1).
We probed the critical aggregation concentrations (CACs)
using a Nile Red assay in PBS buﬀer.16 The CACs of C16-L-Lys
and C16-D-Lys were 33  3 mM and 29  4 mM respectively, while
those of C16-Gly-L-Lys and C16-Gly-D-Lys were 31  3 mM and
28  3 mM (Table 1). As such, all compounds had similar CACs,
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Table 1 Characterisation of C16-L-Lys, C16-D-Lys, C16-Gly-L-Lys and C16-
Gly-D-Lys. Extracted CD data (lmax and ellipticity), critical aggregation
concentrations (CACs) from Nile Red (NR) assay (10 mM PBS, 45 1C) and
ITC demicellisation experiments (10 mM Tris/HCl, 150 mM NaCl), DLS data
(diameter and zeta potential, 10 mM Tris/HCl, 150 mM NaCl)
CD
lmax/nm
[y/mdeg]
NR
CAC/mM
ITC
CAC/mM
DLS
Diameter/
nm
DLS
Zeta pot/mV
C16-L-Lys 218.5 [+5.1] 33  3 45 6.2  1.7 +45.2  1.6
C16-D-Lys 218.5 [5.1] 29  4 48 6.3  1.7 +39.2  1.6
C16-Gly-L-Lys 230 [+1.3] 31  3 49 120  57 +40.1  2.2
C16-Gly-D-Lys 230 [1.3] 28  3 47 83  50 +47.1  1.4
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and as expected, the enantiomers behaved identically (within
error). We also used isothermal calorimetry (ITC) to determine
CACs via a demicellisation experiment, diluting a concentrated
SAMul ligand solution (Tris HCl 10 mM; NaCl 150 mM). Once
again, all compounds exhibited similar CACs (Table 1). These
values are slightly diﬀerent to those determined by Nile Red
assay, but that is to be expected as the experimental conditions
are somewhat diﬀerent (and in the case of ITC matched to the
polyanion binding experiments, see below).
Transmission electron microscopy (TEM) was used to visua-
lise the self-assembled morphologies formed on drying aqu-
eous solutions. All four compounds aggregated into similar
micellar assemblies, with approximate diameters of ca. 8 nm
(Fig. 3 and ESI†). Dynamic light scattering (DLS) was used to
further characterise these self-assembled nanostructures in
solution (Table 1). Both C16-L-Lys and C16-D-Lys formed aggre-
gates ca. 6.3 nm in diameter, assigned as spherical micelles.
Perhaps surprisingly, however, C16-Gly-L-Lys and C16-Gly-D-Lys
appeared to form larger solution-phase assemblies with dia-
meters of ca. 120 nm and ca. 83 nm respectively, and large size
distributions. Clearly C16-Gly-L-Lys and C16-Gly-D-Lys are more
prone than C16-L-Lys and C16-D-Lys to further aggregation,
which must stem from the molecular-level insertion of the
glycine spacer. However, DLS was performed at elevated con-
centrations (0.5 mg ml1, 1 mM) which can impact on self-
assembled morphology. We therefore also performed DLS at
lower concentrations (down to 100 mM) to better reflect assay
conditions, and found much greater contribution from smaller
nanostructures (see ESI†).
The zeta potentials of C16-L-Lys, C16-D-Lys, C16-Gly-L-Lys and
C16-Gly-D-Lys were all similar and positive, reflecting protona-
tion of lysine at physiological pH. As such, all systems formed
self-assembled cationic nanostructures, expected to bind poly-
anionic heparin or DNA – the enantiomeric pairs existing as
charge-dense identical (mirror-image) aggregates.
The DNA binding ability of C16-L-Lys and C16-D-Lys was
initially quantified by displacement of ethidium bromide
(EthBr) from its complex with DNA monitored by fluorescence
spectroscopy in HEPES buﬀer (Fig. 2).17 The CE50 value is the
charge excess required for 50% displacement of EthBr, and
EC50 is the concentration of binder at the same point (Table 2).
The EC50 values are below the CACs of these ligands – it is well-
known that polyanion binding can assist cationic lipid assembly by
limiting electrostatic repulsion at the charged SAMul surface.18 C16-
L-Lys and C16-D-Lys had identical binding profiles (Fig. 2A) and
identical CE50 values (Table 2), suggesting these enantiomeric self-
assemblies bind DNA in identical ways – i.e., self-assembled
nanoscale chirality has no significant impact on the molecular
recognition interface. Conversely, the EthBr displacement assay
indicated that the DNA binding ability of C16-Gly-L-Lys and C16-Gly-
D-Lys was significantly different (Fig. 2C), with the former having a
CE50 of 3.8 0.7 but the latter having a CE50 of 1.5 0.1, indicating
much better binding (Table 2). Clearly DNA has a significant
preference between these enantiomeric assemblies. This would
suggest that on introducing the glycine spacer, the lysine ligands
are better able to express their chirality at the nanoscale binding
interface, and as such, the molecular structure of each ligand
matters, rather than the overall charge density of the SAMul
nanostructure being the only factor controlling binding.
Heparin binding was quantified using a Mallard Blue (MalB)
competition assay in which the displacement of MalB from its
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Fig. 1 Compounds investigated in this paper. And schematic of self-
assembled multivalent (SAMul) binding of polyanions.
Fig. 2 Graphs from competition assays. Top: C16-L-Lys (blue) and C16-D-
Lys (red) with (A) DNA and (B) heparin. Bottom: C16-Gly-L-Lys (blue) and
C16-Gly-D-Lys (red) with (C) DNA and (D) heparin. EthBr assays have [DNA]
= 4 mM (per base) [EthBr] = 5.07 mM, in HEPES (2 mM), EDTA (0.05 mM) and
NaCl (150 mM). MalB assays have [heparin] = 27 mM (per disaccharide)
[MalB] = 25 mM, in Tris/HCl (10 mM) and NaCl (150 mM).
Table 2 DNA and heparin binding data for C16-L-Lys, C16-D-Lys, C16-Gly-
L-Lys and C16-D-Lys extracted from competition assays with EthBr and
MalB respectively. EthBr assays have [DNA] = 4 mM (per base) [EthBr] = 5.07
mM, in HEPES (2 mM), EDTA (0.05 mM) and NaCl (150 mM). MalB assays
have [heparin] = 27 mM (per disaccharide) [MalB] = 25 mM, in Tris/HCl (10
mM) and NaCl (150 mM)
DNA Heparin
CE50 EC50/mM CE50 EC50/mM
C16-L-Lys 1.6  0.2 3.2  0.4 1.8  0.1 100  3
C16-D-Lys 1.7  0.1 3.4  0.2 1.8  0.1 100  3
C16-Gly-L-Lys 3.8  0.7 7.6  1.3 3.3  0.3 180  17
C16-Gly-D-Lys 1.5  0.1 3.1  0.2 2.3  0.1 122  2
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complex with heparin, is monitored by UV-vis spectroscopy.19
The sigmoidal lineshape (Fig. 2) suggests that no binding takes
place until the concentration of ligand exceeds a critical
concentration – as such, self-assembly is a pre-requisite for
heparin binding. The CE50 values for C16-L-Lys and C16-D-Lys
were identical (Table 2), indicating the chiral information at the
nanoscale surface is not expressed in binding heparin. How-
ever, as for DNA binding, C16-Gly-L-Lys and C16-Gly-D-Lys had
different performances (Fig. 2) with CE50 values of 1.7 0.2 and
1.1  0.1, respectively (Table 2). Chiral discrimination at the
nanoscale binding interface has clearly, been switched on by
the presence of the glycine spacer unit. As for DNA binding,
C16-Gly-D-Lys binds heparin significantly more effectively than
enantiomeric C16-Gly-L-Lys.
We were concerned that binding to polyanions may signifi-
cantly disrupt the nanoscale self-assemblies, leading to struc-
tural reorganisation. We therefore used TEM to image the
SAMul nanostructures in the presence of DNA and heparin.
In all cases, and for both families of ligand, self-assembled
micellar objects appeared to remain intact and co-assemble
with the polyanionic components into clustered hierarchical
structured nano-assemblies (Fig. 3 and ESI†). This hierarchical
assembly is a result of close packing between polycationic
micellar spheres and polyanionic chains. The presence of ‘un-
bound’ micelles in the TEM images arises from excess binder
present in the samples. This imaging demonstrates that micel-
lar stability is high and that self-assembly is not adversely
aﬀected by the presence of highly interactive polyanions.
Given the significant enantioselective binding diﬀerences
induced by the introduction of a glycine spacer unit, we
employed ITC titration methods to confirm these results and
provide greater insight – detailed methodology is presented in
the ESI† – the SAMul systems were maintained well above their
CAC throughout the titration in an attempt to avoid any
thermodynamic contribution associated with de-micellisation.
Binding isotherms are shown in Fig. 4 and thermodynamic
parameters are in Table 3. Overall, heparin is bound more
strongly than DNA – primarily driven by the larger entropic
term. In agreement with the EthBr/MalB displacement assays,
the ITC results confirm that for C16-L-Lys and C16-D-Lys the self-
assembled nanoscale chirality has no significant impact on the
molecular recognition interface (Fig. 4A and B). Further, and
once again in agreement with the competition assays, ITC
indicated significant polyanion binding differences between
C16-Gly-L-Lys and C16-Gly-D-Lys (Fig. 4C and D). Indeed, DNA
displays a very clear preference for C16-Gly-D-Lys over C16-Gly-L-
Lys, with DGbind values of 28.1 kJ mol1 and 25.5 kJ mol1,
respectively (DDGbind = 2.6 kJ mol
1). Furthermore, heparin
binds somewhat better to C16-Gly-D-Lys with DGbind of 29.4 kJ
mol1 than the L enantiomer with DGbind of 28.5 kJ mol1
(DDGbind = 0.9 kJ mol
1).
Polyanion binding in these SAMul systems is exothermic, as
would be expected for ion–ion interactions. The DHbind values
for heparin binding are13.7 and12.3 kJ mol1 for C16-Gly-D-
Lys and C16-Gly-L-Lys respectively (DDHbind = 1.4 kJ mol
1), and
for DNA binding they are15.7 and11.6 kJ mol1 respectively
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Fig. 3 TEM images of self-assembled nanostructures formed by C16-L-
Lys. Images are taken in the absence of polyanion (top, scale bar = 50 nm);
in the presence of heparin (middle, scale bar = 100 nm); in the presence of
DNA (scale bar = 100 nm). All scale bars = 100 nm.
Fig. 4 ITC traces. Top: C16-L-Lys (blue) and C16-D-Lys (red) with (A) DNA
and (B) heparin (inset is measured heat power versus time elapsed during
titration with C16-D-Lys as an example). Bottom: C16-Gly-L-Lys (blue) and
C16-Gly-D-Lys (red) with (C) DNA (inset is measured heat power versus
time elapsed during titration with C16-Gly-D-Lys as an example) and (D)
heparin.
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(DDHbind = 4.1 kJ mol
1). The entropy values are positive, which
suggests a degree of disorder induced by binding as solvent and
ions are released from the nanoscale binding interface. Entropic
differences between enantiomers are somewhat smaller. For
heparin binding, TDSbind values are +15.7 and +16.2 kJ mol
1 for
the D- and L-systems respectively (DTDSbind = 0.5 kJ mol1), while
for DNA binding, these values are +12.5 and +13.9 kJ mol1
respectively (DTDSbind = 1.4 kJ mol1). As such, it is clear that
the enhanced binding of C16-Gly-D-Lys with DNA and also, to a
lesser extent with heparin, is primarily of enthalpic origin. This
enhanced enthalpic effect is slightly offset by a smaller entropic
gain for C16-Gly-D-Lys, but enthalpy dominates. As such, we suggest
that specific ligand-polyanion interactions are optimised on the
surface of the C16-Gly-D-Lys in comparison with C16-Gly-L-Lys. The
lower enantioselectivity of heparin towards these SAMul systems
compared with DNA may result from the more polydisperse nature
of heparin leading to a less well-defined distribution of anionic
binding sites. In DNA, the structure of the polymer is more well-
defined, with anionic sites evenly and repetitively spaced down the
helical backbone, hence potentially benefitting more from an
appropriately structured binding partner.
There are several potential reasons why the glycine spacer
switches on enantioselective binding in this system. Most
likely, as evidenced by DLS, is that the glycine spacer modifies
the polarity and shape of the amphiphile and hence changes
the self-assembled morphology, enabling the optimisation of
the binding interface and greater selectivity. We can rule out
any impact of charge density, as all systems have very similar
zeta potentials. However, it is also possible that the additional
glycine amide hydrogen bonding site may enable more specific
interaction with the binding partner. Determining the relative
importance of these diﬀerent factors is the focus of a larger
ongoing structure–activity relationship study. Clearly, however,
polyanion binding is sensitive to the way ligands are displayed
on the surface of SAMul nanostructures. Understanding such
effects is important in predicting and understanding the selec-
tivity of binding processes at self-assembled bio-surfaces, such
as cell membranes, as well as in optimising binding to nano-
scale biological targets such as these clinically important
polyanions.
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Table 3 DNA and heparin binding data for C16-L-Lys, C16-D-Lys, C16-Gly-
L-Lys and C16-D-Lys extracted from ITC (10 mM Tris/HCl, 150 mMNaCl). All
data are in kJ mol1
DNA Heparin
DGbind DHbind TDSbind DGbind DHbind TDSbind
C16-L-Lys 27.3 14.0 13.3 31.1 14.6 16.5
C16-D-Lys 27.7 15.5 12.1 30.8 14.2 16.6
C16-Gly-L-Lys 25.5 11.6 13.9 28.5 12.3 16.2
C16-Gly-D-Lys 28.1 15.7 12.5 29.4 13.7 15.7
4 | Chem. Commun., 2016, 00, 14 This journal is c The Royal Society of Chemistry 2016
Communication ChemComm
